Search research articles
Contact Us
Filters
Showing results (171-180 of 176) with videos related to
Page
of 18
Sort By:
You have reached the last page of results.
This site can display upto 176 results.
The Lancet. Haematology
|
July 23, 2022
Rates of laboratory adverse events by course in paediatric leukaemia ascertained with automated electronic health record extraction: a retrospective cohort study from the Children's Oncology Group
Tamara P Miller, Kelly D Getz, Yimei Li, et al.
Cancer Genetics
|
May 3, 2016
Current state of pediatric sarcoma biology and opportunities for future discovery: A report from the sarcoma translational research workshop
Pooja Hingorani, Katherine Janeway, Brian D Crompton, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 29, 2020
Paediatric Strategy Forum for medicinal product development of epigenetic modifiers for children: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration
Andrew Dj Pearson, Kimberly Stegmaier, Franck Bourdeaut, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 8, 2014
Toward a drug development path that targets metastatic progression in osteosarcoma
Chand Khanna, Timothy M Fan, Richard Gorlick, et al.
Pediatric Blood & Cancer
|
June 22, 2019
Insights into pediatric rhabdomyosarcoma research: Challenges and goals
Marielle E Yohe, Christine M Heske, Elizabeth Stewart, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 21, 2020
Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration
Andrew D J Pearson, C Michel Zwaan, E Anders Kolb, et al.
Page
of 18
Search research articles
Search
Showing results (171-180 of 176) with videos related to
Sort By:
Page
of 18
You have reached the last page of results.
This site can display upto 176 results.
The Lancet. Haematology
|
July 23, 2022
Rates of laboratory adverse events by course in paediatric leukaemia ascertained with automated electronic health record extraction: a retrospective cohort study from the Children's Oncology Group
Tamara P Miller, Kelly D Getz, Yimei Li, et al.
Cancer Genetics
|
May 3, 2016
Current state of pediatric sarcoma biology and opportunities for future discovery: A report from the sarcoma translational research workshop
Pooja Hingorani, Katherine Janeway, Brian D Crompton, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 29, 2020
Paediatric Strategy Forum for medicinal product development of epigenetic modifiers for children: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration
Andrew Dj Pearson, Kimberly Stegmaier, Franck Bourdeaut, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 8, 2014
Toward a drug development path that targets metastatic progression in osteosarcoma
Chand Khanna, Timothy M Fan, Richard Gorlick, et al.
Pediatric Blood & Cancer
|
June 22, 2019
Insights into pediatric rhabdomyosarcoma research: Challenges and goals
Marielle E Yohe, Christine M Heske, Elizabeth Stewart, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 21, 2020
Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration
Andrew D J Pearson, C Michel Zwaan, E Anders Kolb, et al.
Page
of 18